Evidence map›Paper›PMID 8500598›Full record

ReviewExperientia1993

Nervous tissue proteoglycans.

R K Margolis, R U Margolis

Abstract readReview
PubMed Publisher
In one paragraph

Review in Experientia, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 265 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Fluid transport in the brain.Physiological reviews · 2022
    Review
  5. Axonal Regeneration by Glycosaminoglycan.Frontiers in cell and developmental biology · 2021
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Molecular evolution of teleost neural isozymes.Journal of molecular evolution · 2012
    Article
  13. Keratan sulfate restricts neural plasticity after spinal cord injury.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2011
    Article
  14. Diffusion in brain extracellular space.Physiological reviews · 2008
    Review
  15. Review
  16. Recapitulate development to promote axonal regeneration: good or bad approach?Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2006
    Review
  17. Versican in the developing brain: lamina-specific expression in interneuronal subsets and role in presynaptic maturation.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2005
    Article
  18. Keratan sulfate proteoglycan phosphacan regulates mossy fiber outgrowth and regeneration.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2004
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

R K MargolisDepartment of Pharmacology, State University of New York, Brooklyn 11203.
R U Margolis
New York University · US

Funding

COMPLEX CARBOHYDRATES OF NERVOUS TISSUER01NS013876 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MARGOLIS, RICHARD U · 1985 to 2001
$598k
STUDIES ON NERVOUS TISSUE GLYCOCONJUGATESR01NS009348 · NINDS · SUNY DOWNSTATE MEDICAL CENTER · PI MARGOLIS, RICHARD U · 1985 to 2000
$307k
NIMH NIH HHS MH-00129NINDS NIH HHS NS-09348NINDS NIH HHS NS-13876
6 · The paper itself

Abstract

The structure, biosynthesis, localization, and possible functional roles of nervous tissue glycosaminoglycans and proteoglycans were last reviewed several years ago. Since that time, there has been an exponential increase in publications on the neurobiology of proteoglycans. This review will therefore focus on reports which have appeared in the period after 1988, and especially on those concerning the properties of individual characterized nervous tissue proteoglycans. Related areas such as the regulation of glycosaminoglycan biosynthesis and the roles of cell surface proteoglycans in adhesion and growth control are covered in other contributions to this special topic issue.

Indexed as

Nervous System Physiological PhenomenaAmyloid beta-PeptidesAnimalsBrainCell Adhesion Molecules, NeuronalChondroitin Sulfate ProteoglycansChromograninsGlycosylphosphatidylinositolsHeparan SulfateHumansKeratan SulfateLectins, C-TypeMembrane GlycoproteinsNerve Tissue ProteinsNeuritesProteoglycansAmyloid beta-PeptidesCell Adhesion Molecules, NeuronalChondroitin Sulfate ProteoglycansChromograninsGlycosylphosphatidylinositolsHeparan SulfateKeratan SulfateLectins, C-TypeMembrane GlycoproteinsNerve Tissue ProteinsProteoglycansSyndecansVCAN protein, humanVersicans

Identifiers

PMID8500598
OpenAlexW1966538134

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.